Bio Impact Capital LLC Biocryst Pharmaceuticals Inc Transaction History

Bio Impact Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$10.79 - $14.81 $360,666 - $495,039	-33,426 Reduced 5.23%	605,663 $7.63 Million
Q1 2022 May 13, 2022	SELL	$11.56 - $19.76 $264,284 - $451,753	-22,862 Reduced 3.45%	639,089 $10.4 Million
Q4 2021 Feb 11, 2022	SELL	$11.18 - $15.46 $478,682 - $661,935	-42,816 Reduced 6.08%	661,951 $9.17 Million
Q3 2021 Nov 15, 2021	BUY	$14.21 - $17.65 $10 Million - $12.4 Million	704,767 New	704,767 $10.1 Million

279

172M

625K

739K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.41B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Bio Impact Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Bio Impact Capital LLC with notifications on news.